PharmGen Science Inc (004720) — Cash Flow Quality Index
PharmGen Science Inc (004720) has a Cash Flow Quality Index of 0.92x as of December 2024. Operating cash flow of ₩3.40 Billion is below net income of ₩3.71 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 004720 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PharmGen Science Inc Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for PharmGen Science Inc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of PharmGen Science Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for PharmGen Science Inc (2015–2024)
Year-by-year earnings quality comparison for PharmGen Science Inc. For live market cap and the full company financial profile, see PharmGen Science Inc (004720) market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.85x | ₩2.38 Billion | ₩2.79 Billion | ▼ -4.4% |
| 2023 | 0.89x | ₩5.44 Billion | ₩6.09 Billion | ▲ +4965.7% |
| 2022 | -0.02x | ₩-1.29 Billion | ₩70.06 Billion | ▼ -107.7% |
| 2021 | 0.24x | ₩7.78 Billion | ₩32.47 Billion | ▼ -17.4% |
| 2020 | 0.29x | ₩2.68 Billion | ₩9.22 Billion | ▼ -96.5% |
| 2019 | 8.36x | ₩2.52 Billion | ₩301.98 Million | ▲ +785.7% |
| 2018 | 0.94x | ₩4.22 Billion | ₩4.47 Billion | ▲ +121.8% |
| 2017 | 0.43x | ₩1.84 Billion | ₩4.32 Billion | ▼ -81.1% |
| 2016 | 2.25x | ₩7.75 Billion | ₩3.45 Billion | ▲ +28.2% |
| 2015 | 1.75x | ₩3.62 Billion | ₩2.07 Billion | — |